MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2022 International Congress

    Validation of a patient-reported functional mobility composite score (FMCS) in people with typical Parkinson’s disease

    AMH. Hanff, A. Rauschenberger, C. Mccrum, G. Aguayo, M. Zeegers, A. Leist, R. Krüger (Strassen, Luxembourg)

    Objective: To investigate the convergent and discriminative validity of a patient-reported FMCS in people with typical PD (PwP). Background: Although a patient-reported instrument is less…
  • 2022 International Congress

    Estimating the Meaningful Within-Patient Change Threshold for the MDS-UPDRS Part III

    S. Zanigni, D. Trundell, A. Monnet, N. Shariati, E. Moore, E. Davies, N. Pross, G. Pagano, T. Nikolcheva (Basel, Switzerland)

    Objective: To estimate the meaningful within-patient worsening threshold (MWPWT) of the Movement Disorders Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS Part III in early-stage Parkinson's disease…
  • 2022 International Congress

    Cerebellar and other motor symptoms in Huntington’s Disease: A multiple scale correlation study

    D. López-Mena, H. Martinez-Hernandez, J. Arista-Ramírez (Ciudad de Mexico, Mexico)

    Objective: To describe the cerebellar symptoms and other accompanying movement disorders in Huntington's Disease (HD). Background: HD is a pathological entity whose etiological substrate is…
  • MDS Virtual Congress 2021

    Translation and validation of two Parkinson’s disease specific burden questionnaires from German into French.

    S. Bayen, J. Heutte, J-C. Vanderbecken, C. Moreau, L. Defebvre, W. Messaadi, D. Devos, N. Messaadi (Lille, France)

    Objective: The study purpose was to translate the questionnaires and to evaluate their internal consistency and temporal stability in a French study population, composed of…
  • MDS Virtual Congress 2021

    Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

    H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)

    Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…
  • MDS Virtual Congress 2021

    The impact of gender identity and gender role orientation on health-related quality of life in people with Parkinson’s disease.

    I. Göttgens, S. Darweesh, B. Bloem, S. Oertelt-Prigione (Nijmegen, Netherlands)

    Objective: To assess the associations of gender identity and gender role orientation with health-related quality of life (HRQoL) among persons with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To investigate satisfaction with daily remote monitoring with a digital health technology tool (DHTT) in individuals with early Parkinson’s disease (PD) and the relationship…
  • MDS Virtual Congress 2021

    Emergence of new symptoms in experiences of daily living in early Parkinson’s disease

    J. Cedarbaum, M. Tosin, T. Simuni, G. Stebbins (Woodbridge, USA)

    Objective: To explore the utility of assessing emergence of new symptoms (ES) impacting the daily experiences of patients with early Parkinson’s disease (PD) in relation…
  • MDS Virtual Congress 2021

    The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To examine the experience profile of PD Diary raters in clinical trials Background: The Parkinson’s Disease (PD) Home Diary (Hauser, 2000)1 is a widely…
  • MDS Virtual Congress 2021

    Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

    D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)

    Objective: To test whether The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III (Motor Examination) items provide increased sensitivity…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley